Pharmacology Daily: Recent Episodes

Circle Of Insight Productions

Dr. Carlos discusses the latest research and news on pharmacology, medications, and street drugs.

View Details

David J. Hellerstein, M.D., is a research psychiatrist at the New York State Psychiatric Institute, New York, NY, and Professor of Clinical Psychiatry at the Columbia University Irving Medical Center. He specializes in research and treatment of mood and anxiety disorders, particularly the medication treatment of chronic depression. His current studies include psilocybin in treatment-resistant depression, ganaloxone for postpartum depression, and lumateperone for bipolar depression.

Dr. Hellerstein is Director of the Depression Evaluation Service, which conducts studies on the medication and psychotherapy treatment of conditions including major depression, chronic depression, and bipolar disord

View Details

Professor Hutchison of University of Colorado

View Details

George F. Koob, Ph.D., is an internationally-recognized expert on alcohol and stress, and the neurobiology of alcohol and drug addiction. He is the Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), where he provides leadership in the national effort to reduce the public health burden associated with alcohol misuse. As NIAAA Director, Dr. Koob oversees a broad portfolio of alcohol research ranging from basic science to epidemiology, diagnostics, prevention, and treatment.